BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20381931)

  • 1. [Fanconi syndrome associated with tenofovir treatment: a presentation of two cases].
    Vilchez-Aparicio V; Mir M; Rodríguez B; Sanz J
    Enferm Infecc Microbiol Clin; 2010 Nov; 28(9):653-4. PubMed ID: 20381931
    [No Abstract]   [Full Text] [Related]  

  • 2. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature.
    Quimby D; Brito MO
    AIDS Read; 2005 Jul; 15(7):357-64. PubMed ID: 16044577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
    Malik A; Abraham P; Malik N
    J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment: tenofovir nephrotoxicity--vigilance required.
    Fine DM
    AIDS Read; 2005 Jul; 15(7):362-3. PubMed ID: 16044578
    [No Abstract]   [Full Text] [Related]  

  • 5. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
    Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
    AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
    Atta MG; Fine DM
    AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
    [No Abstract]   [Full Text] [Related]  

  • 7. Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.
    Shepp DH; Curtis S; Rooney JF
    AIDS; 2007 Jul; 21(11):1479-81. PubMed ID: 17589195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.
    Winston J; Shepp DH
    HIV Med; 2006 Oct; 7(7):484-5. PubMed ID: 16925736
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
    Perrot S; Aslangul E; Szwebel T; Caillat-Vigneron N; Le Jeunne C
    J Clin Rheumatol; 2009 Mar; 15(2):72-4. PubMed ID: 19265350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
    Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
    HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
    de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
    Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment: Fanconi syndrome and tenofovir--understanding proximal tubular function.
    Fine DM
    AIDS Read; 2007 Jun; 17(6):326-7. PubMed ID: 17632941
    [No Abstract]   [Full Text] [Related]  

  • 13. Fanconi syndrome and renal failure induced by tenofovir: a first case report.
    Verhelst D; Monge M; Meynard JL; Fouqueray B; Mougenot B; Girard PM; Ronco P; Rossert J
    Am J Kidney Dis; 2002 Dec; 40(6):1331-3. PubMed ID: 12460055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
    Brim NM; Cu-Uvin S; Hu SL; O'Bell JW
    AIDS Read; 2007 Jun; 17(6):322-8, C3. PubMed ID: 17632940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tenofovir associated hypokalaemia in a patient with normal renal function].
    Elizalde A; Len O; Perelló M; Ribera E
    Enferm Infecc Microbiol Clin; 2010 Nov; 28(9):655-6. PubMed ID: 20381923
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
    Rifkin BS; Perazella MA
    Am J Med; 2004 Aug; 117(4):282-4. PubMed ID: 15308442
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
    Jaafar A; Séronie-Vivien S; Malard L; Massip P; Chatelut E; Tack I
    AIDS; 2009 Jan; 23(2):257-9. PubMed ID: 19098496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir and changes in renal function.
    Flandre P
    AIDS; 2010 Feb; 24(4):619-20. PubMed ID: 20195075
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.
    Lockhart SM; Rathbun RC; Stephens JR; Baker DL; Drevets DA; Greenfield RA; Salvaggio MR; Vincent S
    AIDS; 2007 Jun; 21(10):1370-3. PubMed ID: 17545718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir and changes in renal function.
    Gupta SK
    Clin Infect Dis; 2005 Aug; 41(4):570-1; author reply 571. PubMed ID: 16028175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.